Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1986 Apr;55(4):391–399. doi: 10.1136/hrt.55.4.391

Afterload reduction: a comparison of captopril and nifedipine in dilated cardiomyopathy.

P G Agostoni, N De Cesare, E Doria, A Polese, G Tamborini, M D Guazzi
PMCID: PMC1236744  PMID: 3516187

Abstract

Nifedipine and captopril are potent vasodilators and may be expected to help left ventricular failure by reducing afterload. Nifedipine (20 mg three times a day) and captopril (50 mg three times a day) were added to an optimal regimen of digitalis and diuretics in a double blind crossover trial in 18 cases of dilated cardiomyopathy. New York Heart Association functional class rating symptoms and exercise tolerance times improved on captopril but not on nifedipine. The reduction in pulmonary capillary wedge pressure and the increase of cardiac output on captopril indicated that the augmented functional capacity may have resulted in part from an improved performance of the left ventricle. Although there were comparable decreases in systemic vascular resistance and presumably in impedence to ejection by the left ventricle on both drugs, the dimensions of the ventricular cavity were found to be reduced by captopril and augmented by nifedipine, and only captopril reduced the afterload (wall stress). In addition, the force-length relation (between left ventricular end systolic stress and end systolic diameter) was shifted to the left of baseline by captopril and to the right by nifedipine, suggesting that muscle contractility was reduced by nifedipine and not by captopril. These results suggest that nifedipine and captopril have different effects on afterload and contractility and these may account for the different effects of these drugs on the performance of the heart and clinical responses.

Full text

PDF
391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams W. B., Davies R. O., Ferguson R. K. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy. Fed Proc. 1984 Apr;43(5):1314–1321. [PubMed] [Google Scholar]
  2. Ader R., Chatterjee K., Ports T., Brundage B., Hiramatsu B., Parmley W. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor. Circulation. 1980 May;61(5):931–937. doi: 10.1161/01.cir.61.5.931. [DOI] [PubMed] [Google Scholar]
  3. Cohn J. N., Franciosa J. A. Vasodilator therapy of cardiac failure: (first of two parts). N Engl J Med. 1977 Jul 7;297(1):27–31. doi: 10.1056/NEJM197707072970105. [DOI] [PubMed] [Google Scholar]
  4. Dargie H. J., Ball S. G., Atkinson A. B., Robertson J. I. Converting enzyme inhibitors in hypertension and heart failure. Br Heart J. 1983 Apr;49(4):305–308. doi: 10.1136/hrt.49.4.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Davis R., Ribner H. S., Keung E., Sonnenblick E. H., LeJemtel T. H. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme. N Engl J Med. 1979 Jul 19;301(3):117–121. doi: 10.1056/NEJM197907193010301. [DOI] [PubMed] [Google Scholar]
  6. Fouad F. M., El-Tobgi S., Tarazi R. C., Bravo E. L., Hart N. J., Shirey E. K., Lim J. Captopril in congestive heart failure resistant to other vasodilators. Eur Heart J. 1984 Jan;5(1):47–54. doi: 10.1093/oxfordjournals.eurheartj.a061551. [DOI] [PubMed] [Google Scholar]
  7. Grossman W., Jones D., McLaurin L. P. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 1975 Jul;56(1):56–64. doi: 10.1172/JCI108079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Guazzi M. D., Cipolla C., Della Bella P., Fabbiocchi F., Montorsi P., Sganzerla P. Disparate unloading efficacy of the calcium channel blockers, verapamil and nifedipine, on the failing hypertensive left ventricle. Am Heart J. 1984 Jul;108(1):116–123. doi: 10.1016/0002-8703(84)90553-2. [DOI] [PubMed] [Google Scholar]
  9. Guazzi M. D., De Cesare N., Galli C., Salvioni A., Tramontana C., Tamborini G., Bartorelli A. Calcium-channel blockade with nifedipine and angiotensin converting-enzyme inhibition with captopril in the therapy of patients with severe primary hypertension. Circulation. 1984 Aug;70(2):279–284. doi: 10.1161/01.cir.70.2.279. [DOI] [PubMed] [Google Scholar]
  10. Levine T. B., Franciosa J. A., Cohn J. N. Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure. Circulation. 1980 Jul;62(1):35–41. doi: 10.1161/01.cir.62.1.35. [DOI] [PubMed] [Google Scholar]
  11. Ludbrook P. A., Tiefenbrunn A. J., Reed F. R., Sobel B. E. Acute hemodynamic responses to sublingual nifedipine: dependence on left ventricular function. Circulation. 1982 Mar;65(3):489–498. doi: 10.1161/01.cir.65.3.489. [DOI] [PubMed] [Google Scholar]
  12. Massie B. M., Kramer B. L., Topic N. Long-term captopril therapy for chronic congestive heart failure. Am J Cardiol. 1984 May 1;53(9):1316–1320. doi: 10.1016/0002-9149(84)90086-9. [DOI] [PubMed] [Google Scholar]
  13. Matsumoto S., Ito T., Sada T., Takahashi M., Su K. M., Ueda A., Okabe F., Sato M., Sekine I., Ito Y. Hemodynamic effects of nifedipine in congestive heart failure. Am J Cardiol. 1980 Sep;46(3):476–480. doi: 10.1016/0002-9149(80)90018-1. [DOI] [PubMed] [Google Scholar]
  14. Packer M., Medina N., Yushak M., Meller J. Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure. Circulation. 1983 Oct;68(4):803–812. doi: 10.1161/01.cir.68.4.803. [DOI] [PubMed] [Google Scholar]
  15. Polese A., Fiorentini C., Olivari M. T., Guazzi M. D. Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema. Am J Med. 1979 May;66(5):825–830. doi: 10.1016/0002-9343(79)91123-9. [DOI] [PubMed] [Google Scholar]
  16. Reichek N., Wilson J., St John Sutton M., Plappert T. A., Goldberg S., Hirshfeld J. W. Noninvasive determination of left ventricular end-systolic stress: validation of the method and initial application. Circulation. 1982 Jan;65(1):99–108. doi: 10.1161/01.cir.65.1.99. [DOI] [PubMed] [Google Scholar]
  17. Swedberg K., Hjalmarson A., Waagstein F., Wallentin I. Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. Br Heart J. 1980 Aug;44(2):117–133. doi: 10.1136/hrt.44.2.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Vidt D. G., Bravo E. L., Fouad F. M. Medical intelligence drug therapy: captopril. N Engl J Med. 1982 Jan 28;306(4):214–219. doi: 10.1056/NEJM198201283060405. [DOI] [PubMed] [Google Scholar]
  19. Weber K. T., Janicki J. S. Instantaneous force-velocity-length relations: experimental findings and clinical correlates. Am J Cardiol. 1977 Nov;40(5):740–747. doi: 10.1016/0002-9149(77)90191-6. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES